25 May 2013
Keywords: tentative, fda, ok, osi/genentech, tarceva, drugmakers, osi
Article | 19 September 2005
US drugmakers OSI Pharmaceuticals and Genentech says that the oncologic drug advisory committee of the Food and Drug Administration has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 September 2005
24 May 2013
© 2013 thepharmaletter.com